<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0002020'>Gastroesophageal reflux disease</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e>) is the condition that results when gastric material that refluxes into the esophagus or oropharynx causes symptoms, tissue injury, or both </plain></SENT>
<SENT sid="1" pm="."><plain>Endoscopic examination usually is not required merely to establish a diagnosis of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e>, but endoscopy is the best diagnostic test for <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo>, a sequela of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> that predisposes to esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>Patients found to have <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> will require regular endoscopic surveillance for early, curable <z:hpo ids='HP_0002664'>neoplasia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Esophageal pH monitoring is useful for patients who have symptoms or signs suggestive of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e>, but who have little or no response to antisecretory therapy </plain></SENT>
<SENT sid="4" pm="."><plain>For patients who have severe, ulcerative reflux <z:hpo ids='HP_0100633'>esophagitis</z:hpo>, the clinician has only two reasonable therapeutic options: (1) lifelong antisecretory therapy with <z:chebi fb="0" ids="49200">proton pump inhibitors</z:chebi> or (2) antireflux surgery </plain></SENT>
<SENT sid="5" pm="."><plain>There are no absolute indications for antireflux surgery, but the operation can be considered for patients with severe <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> who are unwilling to accept lifelong medical therapy or for young patients whose <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">GERD</z:e> symptoms respond only to <z:chebi fb="0" ids="49200">proton pump inhibitors</z:chebi> administered in high dosages </plain></SENT>
</text></document>